![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Cost-Effectiveness of Boceprevir Use in Patients with Chronic Hepatitis C Genotype-1 Who Failed Prior Treatment with Peginterferon/Ribavirin
|
|
|
Reported by Jules Levin
AASLD No 5-8 2011 SF
J. Chhatwal,1* S.A. Ferrante,2 E.J. Dasbach,2 A. El Khoury,2 B. Bacon,3 M. Burroughs,2 R. Esteban-Mur,4 C. Brass,2 E. Elbasha2
1University of Pittsburgh, Pittsburgh, PA, 2Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA, 3Saint Louis University School of Medicine, St. Louis, MO, USA, 4Servei de Medicine Interna-Hepatologia, Valle Hebron Hospital, Barcelona, Spain
![AASLD1.gif](../images/112811/112811-2/AASLD1.gif)
![AASLD2.gif](../images/112811/112811-2/AASLD2.gif)
![AASLD3.gif](../images/112811/112811-2/AASLD3.gif)
![AASLD4.gif](../images/112811/112811-2/AASLD4.gif)
![AASLD5.gif](../images/112811/112811-2/AASLD5.gif)
![AASLD6.gif](../images/112811/112811-2/AASLD6.gif)
![AASLD7.gif](../images/112811/112811-2/AASLD7.gif)
![AASLD8.gif](../images/112811/112811-2/AASLD8.gif)
![AASLD9.gif](../images/112811/112811-2/AASLD9.gif)
![AASLD10.gif](../images/112811/112811-2/AASLD10.gif)
![AASLD11.gif](../images/112811/112811-2/AASLD11.gif)
![AASLD12.gif](../images/112811/112811-2/AASLD12.gif)
![AASLD13.gif](../images/112811/112811-2/AASLD13.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|